Novelion Therapeutics Announces January 16, 2020 Effective Date for Commencement of Voluntary Liquidation
January 09, 2020 19:01 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced the definitive date for commencement of...
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
January 03, 2020 08:25 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 03, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today provided updates on the status of the Company’s...
Novelion Therapeutics Provides Update on Effective Date of Liquidation
December 11, 2019 07:46 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced that a hearing date has not yet been scheduled...
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
November 21, 2019 17:51 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today provided updates on the status of the Company’s...
Novelion Therapeutics Announces Results of 2019 Annual General Meeting of Shareholders
November 05, 2019 12:33 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced the results of its 2019 Annual General Meeting...
Novelion Therapeutics Announces New Trading Symbol
October 09, 2019 17:57 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) announced that, effective as of the...
Novelion Therapeutics Announces Nasdaq Delisting
October 08, 2019 08:10 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that on October 7, 2019 the...
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
October 03, 2019 18:21 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its...
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers
September 25, 2019 08:25 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press...
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
September 11, 2019 17:50 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press...